Consistent with our results obtained with anti-Lewis Y CAR T cells, NR4A2/A1R engineered anti-HER2 CAR T cells exhibited significantly enhanced cytokine production upon coculture with HER2+ MCF-7 breast tumors (Fig. 3I, and Supplementary Fig. 6C). The gene discussed is ERBB2; the disease is breast neoplasm.